Related Experiment Video
Updated: Jun 12, 2026
12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
Published on: February 21, 2011
[Slowly progressive dysarthria in primary lateral sclerosis].
P P Urban1, I Wellach, C Pohlmann
1Abteilung für Neurologie, Asklepios Klinik Barmbek, Rübenkamp 220, 22291, Hamburg, Deutschland. p.urban@asklepios.com
Der Nervenarzt
|June 10, 2010
Summary
Primary Lateral Sclerosis (PLS) can present solely as slowly progressive dysarthria, distinct from ALS and HSP. Differentiation involves disease duration, specific neurophysiological tests, and genetic factors.
Area of Science:
- Neurology
- Neurodegenerative Diseases
Background:
- Primary Lateral Sclerosis (PLS) is a rare, slowly progressive motor neuron disease.
- Clinical presentation can be subtle, with dysarthria as an early or sole symptom.
Observation:
- PLS mimics pseudobulbar palsy, requiring careful differentiation from Amyotrophic Lateral Sclerosis (ALS).
- Key diagnostic indicators for PLS include disease duration of at least 4 years and specific neurophysiological findings.
Findings:
- Distinguishing PLS from ALS relies on prolonged disease course, central pathological magnetic-evoked potentials in the tongue, and absence of EMG-detected denervation.
- Hereditary Spastic Paraplegia (HSP) is differentiated by primary lower limb spasticity, later onset, family history, and potential genetic mutations.
Implications:
- Accurate differentiation is crucial for appropriate patient management and prognosis.
- Understanding these distinctions aids in diagnosing rare neurological disorders and guiding further research.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...